| |
| |
|
| Insider
Information: |
Frates James M |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
318,827 |
|
|
Indirect Shares
|
184,010 |
|
|
| Direct
Value |
$2,276,416 |
|
|
|
Indirect Value
|
$3,859,035 |
|
|
| Total
Shares |
502,837 |
|
|
| Total
Value |
$6,135,451 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alkermes Plc |
ALKS |
SVP, Alks Inc; CFO ALKS |
2020-05-14 |
91,828 |
2020-05-14 |
155,669 |
Premium* |
|
|
Sage Therapeutics, Inc. |
SAGE |
|
2021-06-16 |
1,035 |
2021-06-16 |
1,810 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-04-16 |
225,964 |
2024-04-16 |
26,531 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
262 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• – – |
2012-06-13 |
4 |
OE |
$4.77 |
$11,729 |
D/D |
2,459 |
88,551 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• – – |
2012-06-20 |
4 |
AS |
$16.48 |
$40,524 |
D/D |
(2,459) |
86,092 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• – – |
2012-06-20 |
4 |
OE |
$4.77 |
$11,729 |
D/D |
2,459 |
88,551 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• – – |
2012-06-27 |
4 |
AS |
$16.00 |
$39,344 |
D/D |
(2,459) |
86,092 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• – – |
2012-06-27 |
4 |
OE |
$4.77 |
$11,729 |
D/D |
2,459 |
88,551 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2012-07-03 |
4 |
AS |
$17.61 |
$43,303 |
D/D |
(2,459) |
86,092 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2012-07-03 |
4 |
OE |
$4.77 |
$11,729 |
D/D |
2,459 |
88,551 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2012-07-11 |
4 |
OE |
$4.77 |
$11,734 |
D/D |
2,460 |
88,552 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2012-07-11 |
4 |
AS |
$17.30 |
$42,558 |
D/D |
(2,460) |
86,092 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
45,404 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
85,115 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2016-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
57,778 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2017-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
130,654 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2012-11-18 |
4 |
D |
$19.49 |
$50,810 |
D/D |
(2,607) |
99,711 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2016-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,625 |
26,659 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2017-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,625 |
114,967 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2019-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,625 |
47,316 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-01-06 |
4 |
S |
$36.08 |
$96,481 |
D/D |
(2,658) |
34,009 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2024-01-09 |
4 |
S |
$16.33 |
$44,347 |
D/D |
(2,716) |
112,035 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
79,974 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2017-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
119,966 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
85,369 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2013-11-18 |
4 |
D |
$36.89 |
$108,826 |
D/D |
(2,950) |
100,502 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2018-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
147,039 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2019-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
45,566 |
0 |
- |
|
262 Records found
|
|
Page 3 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
